Working... Menu

Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00005812
Recruitment Status : Terminated (No objective response documented, protocol terminated after 12 patients.)
First Posted : January 27, 2003
Last Update Posted : May 14, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 2004
  Actual Study Completion Date : May 2004
Publications of Results:
Davis TH, Fadul CE, Glantz MJ, et al.: Pilot phase II trial of temozolomide for leptomeningeal metastases: preliminary report. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-460, 2003. ISBN 1932312021